GSK press releases Follow GSK provides update on US settlement of CureVac/BioNTech mRNA patent litigation CureVac will make an upfront settlement of $370 million to GSK https://www.gsk.com/en-gb/media/press-releases/gsk-provides-update-on-us-settlement-of-curevacbiontech-mrna-patent-litigation/ gsk.com
